Be more aware of the current affairs and strive to be a handsome hero.
Release time:
2020-08-14
knows more about the current affairs and strives to be Junjie
. Perhaps many people have no good impression of "those who know the current affairs are Junjie", because in movies and TV plays, villains always like to say this when they recruit rebels, and then they will be treated with extreme contempt by the just side. But objectively speaking, this sentence not only does not have the strong emotional color in movies and TV dramas, but also contains simple philosophy.
"Those who know the times are heroes" comes from "Yan Zi's Spring and Autumn Annals", followed by the sentence "Those who change planes become heroes". The two sentences together mean that only those who can recognize the trend of the times and make changes according to the situation can become outstanding people. Therefore, when Sima Hui recommended talents to Liu Bei in the Three Kingdoms period, he said: "Confucian scholars, vulgar scholars, those who know the current affairs, care about Junjie. There are Wolong and Fengchu here." (Xiangyang Ji)
Governing the country requires "knowing the times" and "changing the times". The same is true for the operation and management of enterprises. With the deepening of reform and opening up, China has become more and more closely connected with the world. National policies and industry environments have changed frequently. The market competition faced by enterprises has become increasingly complex, full of risks, challenges and opportunities. The speed of product replacement and enterprise elimination has also been greatly accelerated. In this case, paying attention to the situation, avoiding risks and seizing opportunities are the survival needs of every enterprise.
In the past ten years, the performance of the peak has been rising year by year, and the business strategy of "following the trend" has played an important role. Industrial integration with central enterprises is "homeopathic". It is "homeopathic" to set up sites in central and southwest China, where the economy is relatively backward and competition is moderate. According to social needs, it is "homeopathic" to enter the big health industry. It is also "homeopathic" to start the development of the drug market for children and infants when the two-child policy is liberalized. The reason why Yunnan's peak has seen a sharp increase in benefits this year, to a large extent, it is the light of the implementation of the national "Belt and Road Initiative" concept, which is even more "homeopathic". Therefore, if you don't talk about "taking advantage of the trend" and just "facing up to the difficulties", it is hard to say whether you can become a "Junjie.
Some people may say that paying attention to the external situation, "keeping abreast of the current situation" and "changing through opportunities" are all matters that should be considered by the decision-making level and the management team of the enterprise. The grass-roots cadres and employees only need to do their work well according to the instructions. But the management team of Daye Peak clearly does not think so. Daye Peak has recently issued regulations that at the monthly work meeting, each department must analyze and report on the risks and opportunities related to its own business. The advantage of this approach is that every manager can actively understand the changes in the external situation, make concerted efforts when the enterprise formulates management measures, and be targeted in the implementation of the work. change the passive "indoctrination" and "requirements" to the active "understanding" and "demand", and the immediacy and flexibility of enterprise management will inevitably be improved. At the same time, the management of the backbone of the way of thinking, information analysis and processing capacity has also been exercised, personal quality has naturally been improved.
Nowadays, self-sufficiency and "building behind closed doors" have long been a distant past, and "change" has become the trend of the times. As a peak person in the new era, whether it is a cadre or an employee, whether it is for the development of the enterprise or to achieve personal growth, they should take the initiative to pay attention to "current affairs", be familiar with "machine changes", and strive to be a "handsome" standing at the forefront of the times ". (Hong Tao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page